Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation
- PMID: 37366255
- DOI: 10.33963/KP.a2023.0137
Tricuspid intervention for less-than-severe regurgitation simultaneously with minimally invasive mitral valve surgery in patients with atrial fibrillation
Abstract
Background: While tackling moderate tricuspid regurgitation (TR) simultaneously with left-side heart surgery is recommended by the guidelines, the procedure is still seldom performed, especially in the minimally invasive setting. Atrial fibrillation (AF) is a known marker of both mortality and TR progression after mitral valve surgery.
Aims: This study aimed to investigatev the safety of performing tricuspid intervention and minimally invasive mitral valve surgery (MIMVS) in patients with preoperative AF.
Methods: We retrospectively analyzed data from the Polish National Registry of Cardiac Surgery Procedures collected between 2006 and 2021. We included all patients who underwent MIMVS (mini-thoracotomy, totally thoracoscopic, or robotic surgery) and had presented with moderate tricuspid regurgitation and AF preoperatively. The primary endpoint was death from any cause at 30 days and at the longest available follow-up after MIMVS with tricuspid intervention vs. MIMVS alone. We used propensity score (PS) matching to account for baseline differences between groups.
Results: We identified 1545 patients with AF undergoing MIMVS, 54.7% were men aged 66.7 (mean [standard deviation, SD], 9.2) years. Of those, 733 (47.4%) underwent concomitant tricuspid valve intervention. At 13 years of follow-up, the addition of tricuspid intervention was associated with 33% higher mortality as compared to MIMVS alone (hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.05-1.69; P = 0.02). PS matching resulted in identifying 565 well-balanced pairs. Concomitant tricuspid intervention did not influence long-term follow-up (HR, 1.01; 95 CI, 0.74-1.38; P = 0.94).
Conclusions: After adjusting for baseline confounders, the addition of tricuspid intervention for moderate tricuspid regurgitation to MIMVS did not increase perioperative mortality nor influence long-term survival.
Keywords: atrial fibrillation; minimally invasive surgery; mitral valve; tricuspid valve.
Similar articles
-
Impact of Surgical Ablation of Atrial Fibrillation on the Progression of Tricuspid Regurgitation and Right-Sided Heart Remodeling After Mitral-Valve Surgery: A Propensity-Score Matching Analysis.J Am Heart Assoc. 2016 Dec 5;5(12):e004213. doi: 10.1161/JAHA.116.004213. J Am Heart Assoc. 2016. PMID: 27919928 Free PMC article.
-
Results of Cryoablation for Atrial Fibrillation Concomitant With Video-Assisted Minimally Invasive Mitral Valve Surgery.Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):271-280. doi: 10.1053/j.semtcvs.2016.04.006. Epub 2016 Apr 21. Semin Thorac Cardiovasc Surg. 2016. PMID: 28043429
-
When should prophylactic maze procedure be considered in patients undergoing mitral valve surgery?Ann Thorac Surg. 2010 May;89(5):1395-401. doi: 10.1016/j.athoracsur.2010.02.018. Ann Thorac Surg. 2010. PMID: 20417751
-
Adjunctive procedures in degenerative mitral valve repair: tricuspid valve and atrial fibrillation surgery.Semin Thorac Cardiovasc Surg. 2007 Summer;19(2):121-6. doi: 10.1053/j.semtcvs.2007.06.002. Semin Thorac Cardiovasc Surg. 2007. PMID: 17870006 Review.
-
Which patient undergoing mitral valve surgery should also have the tricuspid repair?Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):1009-20. doi: 10.1510/icvts.2009.217570. Epub 2009 Sep 24. Interact Cardiovasc Thorac Surg. 2009. PMID: 19778956 Review.
Cited by
-
Concomitant tricuspid surgery for moderate tricuspid regurgitation improves survival in left-sided valve surgery - a meta-analysis.J Cardiothorac Surg. 2025 Jul 12;20(1):294. doi: 10.1186/s13019-025-03464-0. J Cardiothorac Surg. 2025. PMID: 40646622 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical